Category: CN Bio

  • FDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ tech

    The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs. In a statement the firm said the move follows the success of a pilot project to assess the performance of the technology. Based in Cambridge, UK, CN Bio has been working with the FDA […]